Adelene Perkins | Chair and CEO |
Robert Ilaria | CMO |
Larry Bloch | President |
Jayne Kauffman | Senior Executive Coordinator |
Edward Tenthoff | Piper Sandler |
Robyn Karnauskas | Truist Securities |
Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the Company's Second Quarter 2022 Financial Results and Business Update. My name is Joseph, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow.